ESTIMATING BIOAVAILABILITY WHEN CLEARANCE CHANGES IN TIME - THE EFFECT OF MODEL MISSPECIFICATION

被引:3
作者
FATTINGER, KE
VEROTTA, D
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT PHARM & PHARMACEUT CHEM,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT BIOSTAT & EPIDEMIOL,SAN FRANCISCO,CA 94143
关键词
D O I
10.1016/0009-9236(95)90181-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:595 / 599
页数:5
相关论文
共 13 条
[1]   NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION [J].
AKAIKE, H .
IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) :716-723
[2]  
BICKEL PJ, 1977, MATH STATISTICS
[3]  
BOECKMANN AJ, 1989, NONMEM USERS GUIDES
[4]   A COMPARISON BETWEEN MAXIMUM-LIKELIHOOD AND GENERALIZED LEAST-SQUARES IN A HETEROSCEDASTIC LINEAR-MODEL [J].
CARROLL, RJ ;
RUPPERT, D .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1982, 77 (380) :878-882
[5]  
FATTINGER KE, 1994, EXPERIENCES NONPARAM
[6]   ESTIMATING BIOAVAILABILITY WHEN CLEARANCE VARIES WITH TIME [J].
KARLSSON, MO ;
SHEINER, LB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (06) :623-637
[7]  
LAWRENCE KD, 1990, ROBUST REGRESSION
[8]  
RESCIGNO A, 1966, DRUG TRACER KINETICS
[9]   ESTIMATING DIMENSION OF A MODEL [J].
SCHWARZ, G .
ANNALS OF STATISTICS, 1978, 6 (02) :461-464
[10]  
Thompson J.R., 1990, NONPARAMETRIC FUNCTI